IVERIC bio, Inc.
ISEEDelisted Jul 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001410939
IVERIC bio, Inc. was delisted on Jul 11, 2023; its insiders filed their last Form 4 on Jul 13, 2023; 256 institutions reported holding it in 13F filings for Q2 2023, worth $5.33B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding IVERIC bio, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 256 | 2 | 0 | −254 |
| Shares | 135.8M | 26.5K | 0 | −135.7M (−100.0%) |
| Value | $5.33B | $1.04M | $0 | −$5.33B (−100.0%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held IVERIC bio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
None.
Sold out (254)
Institutions that held IVERIC bio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
Showing the largest 100 of 254 by value.
Not filed for Q3 2023 yet (2)
Institutions that held IVERIC bio, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 24,966 | $982.2K |
| Endurance Wealth Management, Inc. | 1,500 | $59.0K |